P. Simmons

Phase 1 Study of Weekly Polyethylene Glycol-Camptothecin in Patients with Advanced Solid Tumors and Lymphomas

A. Tolcher, C. Takimoto, M. Saif, 2005, Clinical Cancer Research.

Multiple Drug-Toxicity Involving Novel Psychoactive Substances, 3-Fluorophenmetrazine and U-47700.

Kayla N. Ellefsen, B. Hall, Vickie Willoughby, 2017, Journal of analytical toxicology.

A Multicenter Phase II Trial of Thalidomide and Celecoxib for Patients with Relapsed and Refractory Multiple Myeloma

V. Ganju, A. Roberts, L. Mileshkin, 2005, Clinical Cancer Research.

A phase II, pharmacokinetic, and biologic study of semaxanib and thalidomide in patients with metastatic melanoma

A. Tolcher, G. Weiss, C. Takimoto, 2007, Cancer Chemotherapy and Pharmacology.

Patients with multiple myeloma treated with thalidomide: evaluation of clinical parameters, cytokines,angiogenic markers, mast cells and marrow CD57+ cytotoxic T cells as predictors of outcome.

M. Trivett, L. Mileshkin, M. Smyth, 2007, Haematologica.

AMulticenter Phase II TrialofThalidomide andCelecoxib for Patients with Relapsed and RefractoryMultipleMyeloma

V. Ganju, A. Roberts, J. Zeldis, 2005 .